First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB

The first successful use of bedaquiline for 18 months for XDR-TB as part of an optimised background regimen http://ow.ly/XE34x

Detalles Bibliográficos
Autores principales: Lewis, Joseph M., Hine, Paul, Walker, Jenny, Khoo, Saye H., Taegtmeyer, Miriam, Squire, S. Bertel, Sloan, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394548/
https://www.ncbi.nlm.nih.gov/pubmed/26917618
http://dx.doi.org/10.1183/13993003.01980-2015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394548/
https://www.ncbi.nlm.nih.gov/pubmed/26917618
http://dx.doi.org/10.1183/13993003.01980-2015

Ejemplares similares